| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101543 Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells |
| 09/05/2006 | US7101542 Cell-mediated targeting of toxins to pathogenic cells |
| 09/05/2006 | US7101541 Utilization of non-viral sequences for minus-strand DNA transfer and gene reconstitution |
| 09/05/2006 | US7101540 Targeted retrograde gene delivery to motor neurons |
| 09/05/2006 | CA2261022C System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 08/31/2006 | WO2006091965A2 Nod1 as an anti-tumor agent |
| 08/31/2006 | WO2006091722A2 Alkyl-glycoside enhanced vaccination |
| 08/31/2006 | WO2006091233A2 Cellular delivery of reagents that inhibit gene expression utilizing the anthrax toxin protective antigen (pa) |
| 08/31/2006 | WO2006091222A2 Methods of treating and preventing severe acute respiratory syndrome (sars) with avr118 |
| 08/31/2006 | WO2006091112A1 Compositions for the delivery of rna interference molecules and methods for their use |
| 08/31/2006 | WO2006090906A1 NOVEL METHOD FOR OVERCOMING RNAi-RESISTANT STRAIN OF VIRUS |
| 08/31/2006 | WO2006090900A1 Preventives/remedies for cancer |
| 08/31/2006 | WO2006090813A1 Element retained in blood showing degradability selectively in tumor tissue |
| 08/31/2006 | WO2006090697A1 Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2 |
| 08/31/2006 | WO2006090689A1 Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector |
| 08/31/2006 | WO2006066247A3 Methods and compositions for extending telomere length and increasing cell lifespan |
| 08/31/2006 | WO2006024694A3 Peptide inhibitors of hk2 and their use |
| 08/31/2006 | WO2006021724A3 Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein |
| 08/31/2006 | WO2005056020A8 Nf-kb oligonucleotide decoy molecules |
| 08/31/2006 | US20060195915 mesencephalic astrocyte-derived neurotrophic factor polypeptide; shown to protect the survival of embryonic mesencephalic dopaminergic neurons in culture |
| 08/31/2006 | US20060194754 Detecting nucleotide sequence using gene expression of reporter molecule |
| 08/31/2006 | US20060194753 Agent for treating leishmania infections |
| 08/31/2006 | US20060194752 Treatment for renal disease |
| 08/31/2006 | US20060194751 Streptococcus pyogenes antigens |
| 08/31/2006 | US20060194750 Methods and materials for modulating trpc4 |
| 08/31/2006 | US20060194740 NOD1 as an anti-tumor agent |
| 08/31/2006 | US20060194734 Cardiac muscle function and manipulation |
| 08/31/2006 | US20060194731 Using tumor antigens to elicit immune response targeted to cancer cells; immunotherapy |
| 08/31/2006 | US20060194730 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 08/31/2006 | US20060194304 Kit comprising sodium chloride, potassium chloride, guanidinium chloride, sodium perchlorate or other chaotropic salt; and a nonionic detergent of Triton, NP40, Tween, or Syperonic, or MOPS buffer; endotoxin-free; purification, centrifuging, chromatography, filtration; gene therapy |
| 08/31/2006 | US20060194293 Rb1 gene induced protein (rb1cc1) and gene |
| 08/31/2006 | US20060194286 Apo-2LI and Apo-3 polypeptides |
| 08/31/2006 | US20060194275 Transporter and ion channels |
| 08/31/2006 | US20060194257 MECP2E1 gene |
| 08/31/2006 | US20060194203 Packing cell system for eb virus vector |
| 08/31/2006 | US20060194199 Method for diagnosing testicular seminomas |
| 08/31/2006 | US20060193920 Nanoparticulate compositions of mitogen-activated protein (map) kinase inhibitors |
| 08/31/2006 | US20060193887 Medical devices having nanoporous bonding layers |
| 08/31/2006 | US20060193886 Medical devices with nanoporous layers and topcoats |
| 08/31/2006 | US20060193884 terpolymer comprising polyoxyalkylene copolymer, polycaprolactone, with copolymerizable monomers such as glycolide, lactide, p-dioxanone and trimethylene carbonate; surgical sutures; for coating medical equipment |
| 08/31/2006 | US20060193874 Vaccines for proliferative ileitis and methods of making and using the same |
| 08/31/2006 | US20060193869 Methods and compositions for induction or promotion of immune tolerance |
| 08/31/2006 | US20060193868 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils |
| 08/31/2006 | US20060193863 Compositions and methods for diagnosing and treating prostate cancer |
| 08/31/2006 | US20060193858 Full-lenth, isolated polypeptide comprising a polypeptide sequence of human SRC-like adaptor protein |
| 08/31/2006 | US20060193855 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 08/31/2006 | US20060193852 immunotherapy, preferably against B-cell malignancies such as non-Hodgkin lymphoma; single-chain multifunctional polypeptides comprising at least two binding sites specific for the CD19 and CD3 antigen; domains are arranged in the order VLCD19-VHCD19-VHCD3-VLCD3; vector; cell |
| 08/31/2006 | US20060193841 Method for the treatment of parkinson's disease |
| 08/31/2006 | US20060193840 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 08/31/2006 | US20060193833 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 08/31/2006 | US20060193832 Use of the sodium iodine symporter to effect uptake of iodine |
| 08/31/2006 | US20060193831 administering to the striatum or substantia nigra of the an amount of pleiotrophin suitable for promoting graft survival and reinnervation of the tissues of the brain and survival of dopaminergic neuron grafts administered to the patient; treats Alzheimer, Parkinson, Huntingtons diesease |
| 08/31/2006 | US20060193830 Raav vector compositions and methods for the treatment of choroidal neovascularization |
| 08/31/2006 | US20060193821 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
| 08/31/2006 | DE19952957B4 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 08/31/2006 | CA2598713A1 Nod1 as an anti-tumor agent |
| 08/30/2006 | EP1696036A1 Use of recombinant adeno-associated virus in the manufacture of a medicament for gene therapy via muscle cells |
| 08/30/2006 | EP1696033A2 Pseudomonas exotoxin A-like chimeric immunogens |
| 08/30/2006 | EP1696028A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1695979A2 Gapped 2' modified oligonucleotides |
| 08/30/2006 | EP1695719A1 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 08/30/2006 | EP1695714A1 Genetically engineered herpes virus for the treatment of tumours |
| 08/30/2006 | EP1695061A2 Method for treating neurological disorders |
| 08/30/2006 | EP1694852A2 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
| 08/30/2006 | EP1694851A2 Viral vectors controlled by a gene switch |
| 08/30/2006 | EP1694815A2 Method and antisense compound for potentiating anti-cancer agents |
| 08/30/2006 | EP1694701A2 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders |
| 08/30/2006 | EP1694364A2 System for treating and preventing breast cancer |
| 08/30/2006 | EP1694361A2 Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 08/30/2006 | EP1694353A2 Composition and methods for modulating cns activity |
| 08/30/2006 | EP1694350A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
| 08/30/2006 | EP1694345A1 Compositions and methods for the treatment of lysosomal storage disorders |
| 08/30/2006 | EP1694301A2 Methods and compositions for the production of monoclonal antibodies |
| 08/30/2006 | EP1694192A2 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 08/30/2006 | EP1297011B1 Diagnostic uses of the t-cell protein tzon7, and of the peptides and antibodies derived therefrom |
| 08/30/2006 | EP1266015B1 Ecdysone receptor-based inducible gene expression system |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1254260B1 Methods for diagnosing and treating heart disease |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1180524B1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 08/30/2006 | EP1171604B1 Dna sequence and recombinant production of a graminae allergen |
| 08/30/2006 | EP1133558B1 Compositions and methods for increasing bone mineralization |
| 08/30/2006 | EP1037900A4 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 08/30/2006 | EP1036174B1 Novel peptide, apoep1.b, compositions and uses thereof |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |
| 08/30/2006 | EP0796104B1 Delivery of nucleic acid molecules to mucosal tissue |
| 08/30/2006 | EP0755450B1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 08/30/2006 | EP0728200B1 Haemophilus transferrin receptor genes |
| 08/30/2006 | CN1826411A Promoter construct for gene expression in neuronal cells |
| 08/30/2006 | CN1824773A Human testicle specificity protein 50 gene expression regulator screening system and method of screening its gene expression regulator |
| 08/30/2006 | CN1824328A Anticancer vaccine and its preparation |
| 08/30/2006 | CN1824327A Preparation method of nucleic acid vaccine guided by using chicken MHC constant chain gene segment |
| 08/30/2006 | CN1824326A Antivirus compounds |
| 08/30/2006 | CN1824325A Human nipple virus DNA inserted vaccine, its preparation method and application |
| 08/30/2006 | CN1824291A Hypersensitivity reaction inhibitor |
| 08/30/2006 | CN1823731A Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 08/30/2006 | CN1272440C Use and constructing method for anticancer recombined gland virus with tumor cell PLK1 as target of medicine |
| 08/30/2006 | CN1272435C Gene of Chinese Mainland SjPP gene stock of Japanese blood fluke, clone, expression and application |